Market Research Reports

Radiopharmaceuticals Market (Generators, PET & SPECT radioiosotopes, Technetium-99m, Gallium-67, Iodine-123, 18F-FDG, Rubidium-82, Yttrium-90 and others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

127pages
Published Date: 2013-02-20
 

Description




Radiopharmaceuticals imply the usage of radiation for non-invasive treatment and diagnosis of various diseases. Utilization of these molecules for medical purposes in PET and SPECT imaging has changed the entire algorithm of disease diagnosis. With rise in the aging population globally coupled with increasing rate of chronic cardiovascular, oncology and neurology diseases, there is tremendous growth potential in this market, especially in developing nations. Similarly, the use of radiolabeled isotopes with peptides and monoclonal antibodies has opened new boulevards for the growth of the global radiopharmaceuticals market. Many radiopharmaceuticals use technetium-99m (Tc-99m) that has many useful properties of gamma-emitting tracer nuclide.

Radiopharmaceuticals are majorly used to diagnose cancer, tumors, biliary tract blockage, bone diseases, bone marrow diseases, brain diseases, colorectal disease, disorders of iron metabolism and absorption, heart disease, heart muscle damage (infarct), impaired flow of cerebrospinal fluid in the brain, kidney diseases, liver diseases, lung diseases, parathyroid diseases, parathyroid cancer, pernicious anemia, improper absorption of vitamin B12 from intestines, red blood cell diseases, salivary gland diseases, spleen diseases, stomach and intestinal bleeding, stomach problems, tear duct blockage, thyroid diseases, thyroid cancer and urinary bladder diseases. 

This may be given to the patient in a number of ways, for e.g. they may be given through the mouth, through injections or placed into the eye or into the bladder. It is a small treatment, which includes use of simple substances containing radioactive isotopes. While treating cancer, these radioactive agents are taken up in the cancerous area to destroy the affected tissues. It works effectively by targeting the areas in the body where the cancer is present. Individuals are suggested to intake radiopharmaceuticals only under the direct supervision of a doctor. 

This report analyses the global scenario of the radiopharmaceuticals market, discussing detailed overview and market figures. The research report analyses the industry growth rate, industry capacity, and industry structure. The report analyses the historical data, and forecasts the radiopharmaceuticals market size, production forecasts along with key factors driving and restraining the market.

The report also analyzes the radiopharmaceuticals market by generators and by further classifying them in terms of medical isotopes, their applications, end users and geographic distribution. The medical isotopes category covers major isotopes used in SPECT and PET imaging like technetium, thallium, gallium, rhenium, yttrium and others. The applications market is further classified into diagnosis and therapy. The end user analysis is done by bifurcation of the market into hospitals and outpatient diagnostic centers.

The geography market has been segmented into four major regions - North America, Europe, Asia-Pacific and Rest of the World (RoW). Some of the top radiopharmaceutical companies in the healthcare market are Covidien Plc, Nordion Inc., Lantheus Medical Imaging, IBA Group, Positron Corporation, Cardinal Health, Eckert & Ziegler among others.

The study presents a comprehensive assessment of the stakeholder strategies, winning imperatives for them by segmenting the radiopharmaceuticals market as below:

Radiopharmaceuticals Market by Generator Types
  • Mo-99/Tc-99m generator
  • Sr-82/Rb-82 generator
  • Ge-68/Ga-68 generator
  • Sr-90/Y-90 generator
  • W-188/Re-188 generator
Radiopharmaceuticals Market by End-Users
  • Hospitals & Medical Centers
  • Diagnostic Centers
Radiopharmaceuticals Market by Applications
  • Diagnosis
  • Diagnosis by Technique
    • SPECT
      • Technetium (Tc-99m)
      • Thallium (TI-201)
      • Gallium (Ga-67)
      • Iodine (I-123)
      • Rhenium (Re-186)
      • Yttrium (Y-90)
      • Others/li>
    • PET
      • Fludeoxyglucose (18F-FDG)
      • Rubidium (Rb-82)
      • Others (Carbon-11 choline, Nitrogen-13 ammonia)
Diagnosis by Indications
  • Oncology
  • Cardiovascular
  • Others (Neurological, Thyroid, Gastrointestinal)
Therapy
  • Systemic Oncology
    • Iodine (I-131)
    • Yttrium (90Y)
    • Samarium (Sm-153)
    • Strontium (89Sr)
    • Rhenium (186Re)
    • Lutetium (Lu-177)
    • Erbium (169Er)
    • Others
  • Others (Cardiology, Neurology)
Radiopharmaceuticals Market by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents




TABLE OF CONTENTS

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Global Radiopharmaceuticals Market Overview
3.1 Overview
3.2 Market Drivers
      3.2.1 Radiopharmaceutical-Based Cancer Therapy
      3.2.2 Growing Preference For Disease-Targeted Therapy
      3.2.3 Increasing Awareness Of Accurate Diagnosis
      3.2.4 Expanding Molecular Imaging Applications
3.3 Market Restraints
      3.3.1 Strict Regulatory Guidelines For Production, Storage and Usage
      3.3.2 Worldwide Supply Shortages
      3.3.3 Price Sensitivity And Competitive Alternatives
3.4 Market Opportunities
      3.4.1 Increasing Demand For Accurate Diagnosis and Treatment, Particularly In Emerging Markets
      3.4.2 Radiopharmaceutical-Based Personalized Therapy

Chapter 4 Market Definition & Supply Chain Analysis
4.1 Market Definition
4.2 Radiopharmaceutical Production : A Global Perspective
4.3 Supply Chain Analysis

Chapter 5 Global Radiopharmaceutical Generators Market
5.1 Overview
      5.1.1 Global Radiopharmaceutical Generators Market, By Revenue, 2010-2018 (USD Million)
5.2 Mo-99/Tc-99m Generators
5.3 Sr-82/Rb-82 Generators
5.4 Ge-68/Ga-67,68 Generators
5.5 Sr-90/Y-90 Generators
5.6 W-188/Re-188 Generators

Chapter 6 Global Radiopharmaceuticals Market, By End-User Groups
6.1 Overview
      6.1.1 Global Radiopharmaceuticals Market By End Users, By Revenue, 2010-2018 (USD Million)
6.2 Hospitals and Medical Centers
      6.2.1 Global Radiopharmaceuticals Market By End User Groups : Hospitals and Medical Centres, 2010 – 2018 (USD Million)
6.3 Outpatient Diagnostic Centers
      6.3.1 Global Radiopharmaceuticals Market By End User Groups: Diagnostic Centres, 2010 – 2018 (USD Million)

Chapter 7 Global Radiopharmaceuticals Market, By Applications
7.1 Overview
7.2 Radiopharmaceuticals For Diagnosis
      7.2.1 Overview
      7.2.2 Radiopharmaceuticals For Diagnosis, By Technique
              7.2.2.1 Single-Photon Emission Computed Tomography (SPECT)
                         7.2.2.1.1 Comparative Analysis: SPECT Radioisotopes Market, 2011 & 2018 (%)
                         7.2.2.1.2 Technetium (Tc-99m)
                         7.2.2.1.3 Thallium (Tl-201)
                         7.2.2.1.4 Gallium (Ga-67)
                         7.2.2.1.5 Iodine (I-123)
                         7.2.2.1.6 Rhenium (Re-186)
                         7.2.2.1.7 Yttrium (Y-90)
                         7.2.2.1.8 Others
             7.2.2.2 Positron Emission Tomography (PET)
                         7.2.2.2.1 Comparative Analysis: PET Radioisotopes Market, 2011 & 2018 (%)
                         7.2.2.2.2 Fludeoxyglucose (18f-FDG)
                         7.2.2.2.3 Rubidium (Rb-82)
                         7.2.2.2.4 Others (Carbon-11 Choline, Nitrogen13 Ammonia)
      7.2.3 Radiopharmaceuticals For Diagnosis, By Indications
              7.2.3.1 Oncology
              7.2.3.2 Cardiovascular
              7.2.3.3 Others (Neurological, Thyroid, Gastrointestinal)
7.3 Radiopharmaceuticals For Therapy
      7.3.1 Overview
      7.3.2 Oncology (Systemic Therapy)
              7.3.2.1 Comparative Analysis: Systemic Therapy Radioisotopes Market, 2011 & 2018 (%)
              7.3.2.2 Iodine (I-131)
              7.3.2.3 Yttrium (Y-90)
              7.3.2.4 Samarium (Sm-153)
              7.3.2.5 Strontium (Sr-89)
              7.3.2.6 Rhenium (186Re)
              7.3.2.7 Lutetium-177 (Lu-177)
              7.3.2.8 Erbium-169 (169Er)
              7.3.2.9 Others
     7.3.3 Other Applications In Therapy (Cardiology, Neurology)
7.4 Theranostics

Chapter 8 Global Radiopharmaceuticals Market, By Geography
8.1 Overview
8.2 North America
     8.2.1 North America Radiopharmaceuticals Market - Diagnosis and Systemic Therapy, 2010-2018 (USD Million)
     8.2.2 North America Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
8.3 Europe
     8.3.1 Europe Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million)
     8.3.2 Europe Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
8.4 Asia-Pacific (Apac)
     8.4.1 Asia-Pacific Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million)
     8.4.2 Asia-Pacific Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
8.5 Rest of the World (RoW)
     8.5.1 RoW Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million)
     8.5.2 RoW Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)

Chapter 9 Market Share Analysis By Key Players
9.1 Radiopharmaceuticals Market
9.2 Generators Market

Chapter 10 Recommendations
10.1 Identification and Elimination Of Barriers
10.2 Development of Total Solutions
10.3 Investing in Emerging Markets
10.4 Entering Monopoly Markets

Chapter 11 Company Profiles
11.1 Cardinal Health Inc.
     11.1.1 Company Overview
     11.1.2 Financial Overview
     11.1.3 Business Strategies
               11.1.3.1 Mergers and Acquisitions
               11.1.3.2 External Funding
               11.1.3.3 Incorporation of Advanced Technologies to Support Business Development
     11.1.4 Product Portfolio
     11.1.5 Recent Developments
11.2 Covidien Plc
     11.2.1 Company Overview
     11.2.2 Product Portfolio
     11.2.3 Financial Overview
     11.2.4 Strategic Overview
               11.2.4.1 Mergers and Acquisitions
               11.2.4.2 Approvals
     11.2.5 Recent Developments
11.3 GE Healthcare
     11.3.1 Company Overview
     11.3.2 Product Portfolio
     11.3.3 Financial Overview
     11.3.4 Strategic Overview
               11.3.4.1 Mergers and Acquisitions
     11.3.5 Recent Developments
11.4 IBA Group
     11.4.1 Company Overview
     11.4.2 Financial Overview
     11.4.3 Product Portfolio
11.5 Lantheus Medical Imaging
     11.5.1 Company Overview
     11.5.2 Financial Overview
     11.5.3 Business Strategies
               11.5.3.1 Rigorous Research and Development Initiatives
               11.5.3.2 Selling Generic Products to Maintain Market Share
     11.5.4 Product Portfolio
               11.5.4.1 Recent Developments
11.6 Monrol Nuclear Products, Inc.
     11.6.1 Company Overview
     11.6.2 Product Portfolio
     11.6.3 Strategic Overview
               11.6.3.1 Mergers and Acquisitions
               11.6.3.2 Collaborations
     11.6.4 Recent Developments
11.7 Nordion, Inc.
     11.7.1 Company Overview
     11.7.2 Product Portfolio
     11.7.3 Financial Overview
     11.7.4 Strategic Overview
               11.7.4.1 Contracts and Agreements
               11.7.4.2 Divestiture
     11.7.5 Recent Developments
               11.7.5.1 New Product Launch
11.8 NTP Radioisotopes (Pty) Ltd
     11.8.1 Company Overview
     11.8.2 Financial Overview
     11.8.3 Business Strategies
               11.8.3.1 Media Campaigns as a Brand Management Tool
               11.8.3.2 Business Expansion through Partnerships, Collaborations and Alliances
     11.8.4 Product Portfolio
     11.8.5 Recent Developments
11.9 Polatom
     11.9.1 Company Overview
     11.9.2 Financial Overview
     11.9.3 Business Strategies
               11.9.3.1 Maintaining an Extensive Network of Distributors
     11.9.4 Product Portfolio
     11.9.5 Recent Developments
11.10 Positron Corporation
     11.10.1 Company Overview
     11.10.2 Product Portfolio
     11.10.3 Financial Overview
     11.10.4 Strategic Overview
                 11.10.4.1 Contracts and Agreements
                 11.10.4.2 Collaborations
     11.10.5 Recent Developments
                 11.10.5.1 Grants and Licenses
                 11.10.5.2 Incentives
11.11 Siemens Healthcare
         11.11.1 Company Overview
         11.11.2 Financial Overview
         11.11.3 Business Strategies
                     11.11.3.1 Investing In Emerging Economies
                     11.11.3.2 Rigorous Research and Development Initiatives
                     11.11.3.3 Identifying Key Growth Areas and Determining Short Term Goals (Agenda 2013)
                     11.11.3.4 Maintaining An Extensive Suppliers Network
         11.11.4 Product Portfolio
         11.11.5 Recent Developments

LIST OF FIGURES

Fig. 1 Radiopharmaceuticals Market Segmentation
Fig. 2 Global Radiopharmaceuticals Market Snapshot
Fig. 3 Global Radiopharmaceuticals Market, By Application, 2011 (USD Million)
Fig. 4 Radiopharmaceuticals Market Attractiveness Analysis, By Geography (2011)
Fig. 5 Global Demand For Tc-99m (2009)
Fig. 6 Supply Chain - Global Radiopharmaceuticals Market
Fig. 7 Global Mo-99/Tc-99m Generators Market, 2010 – 2018 (USD Million)
Fig. 8 Global Sr-82/Rb-82 Generators Market, 2010 – 2018 (USD Million)
Fig. 9 Global Ge-68/Ga-67,68 Generators Market, 2015 – 2018 (USD Million)
Fig. 10 Global Sr-90/Y-90 Generators Market, 2016 – 2018 (USD Million)
Fig. 11 Global W-188/Re-188 Generators Market, 2016 – 2018 (USD Million)
Fig. 12 Global Radiopharmaceuticals Market By End User Groups : Hospitals And Medical Centres, 2010 – 2018 (USD Million)
Fig. 13 Global Radiopharmaceuticals Market By End User Groups: Diagnostic Centres, 2010 – 2018 (USD Million)
Fig. 14 Comparative Analysis: SPECT Radioisotopes Market, 2011 & 2018 (%)
Fig. 15 Global Tc-99m Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 16 Global Tl-201 Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 17 Global Ga-67 Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 18 Global Iodine (I-123) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 19 Global Rhenium (Re-186) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 20 Global Yttrium (Y-90) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 21 Global Others (In SPECT) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 22 Comparative Analysis: PET Radioisotopes Market, 2011 & 2018 (%)
Fig. 23 Global Fludeoxyglucose (18f-FDG) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 24 Global Rubidium (Rb-82) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 25 Global Others (In PET) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 26 Comparative Analysis: Systemic Therapy Radioisotopes Market, 2011 & 2018 (%)
Fig. 27 Global Iodine (I-131) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 28 Global Yttrium (Y-90) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 29 Global Samarium (Sm-153) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 30 Global Strontium (Sr-89) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 31 Global Rhenium (186Re) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 32 Global Lutetium (Lu-177) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 33 Global Erbium (169Er) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 34 Global Other Applications In Therapy Radioisotopes Market, 2010 – 2018 (USD Million)
Fig. 35 Radiopharmaceuticals: Market Share Analysis Of Key Players, 2011 (%)
Fig. 36 Annual Revenues: Cardinal Health Inc., 2010 – 2012 (USD Million)
Fig. 37 Annual Revenues: Covidien Plc, 2009 – 2011 (USD Million)
Fig. 38 Annual Revenues: Ge Healthcare, 2009 – 2011 (USD Million)
Fig. 39 Annual Revenues: IBA Group, 2009 – 2011 (USD Million) (Conversion Rate: 1 Euro = 1.34 USD)
Fig. 40 Annual Revenues: Lantheus Medical Imaging, 2010 – 2011 (USD Million)
Fig. 41 Annual Revenues: Nordion, Inc., 2009 – 2011 (USD Million)
Fig. 42 Annual Revenues: Positron Corporation, 2009 – 2011 (USD Million)
Fig. 43 Annual Revenues: Siemens Healthcare, 2010 – 2011 (USD Million) (Conversion Rate: 1 Euro = 1.34 USD)

LIST OF TABLES

Table 1 Global Radiopharmaceuticals Market By Region, 2010 – 2018 (USD Million)
Table 2 Global Radiopharmaceuticals Generators Market By Segments, 2010 – 2018 (USD Million)
Table 3 Global Radiopharmaceutical Generators Market, By Revenue, 2010-2018 (USD Million)
Table 4 Global Radiopharmaceuticals Market By End Users, By Revenue, 2010-2018 (USD Million)
Table 5 Global Radiopharmaceuticals Market, By Applications, 2010-2018 (USD Million)
Table 6 Global Radiopharmaceuticals Market, By Region, 2010 – 2018 (USD Million)
Table 7 Global Radiopharmaceuticals Market, By Diagnosis, 2010-2018 (USD Million)
Table 8 Global SPECT Market, By Radioisotopes, 2010-2018 (USD Million)
Table 9 Gallium Compounds: Ongoing Studies
Table 10 Global PET Market, By Radioisotopes, 2010-2018 (USD Million)
Table 11 Global Radiopharmaceuticals Therapy Market, By Indications, 2010-2018 (USD Million)
Table 12 Global Systemic Therapy Market, By Radioisotopes, 2010-2018 (USD Million)
Table 13 Radionuclides and Their Applications (Diagnostics/Therapies)
Table 14 Global Radiopharmaceuticals Market By Region, 2010 – 2018 (USD Million)
Table 15 North America Radiopharmaceuticals Market - Diagnosis And Systemic Therapy, 2010-2018 (USD Million)
Table 16 North America Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
Table 17 Europe Radiopharmaceuticals Market- Diagnosis And Systemic Therapy, 2010-2018 (USD Million)
Table 18 Europe Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
Table 19 Asia-Pacific Radiopharmaceuticals Market- Diagnosis And Systemic Therapy, 2010-2018 (USD Million)
Table 20 Asia-Pacific Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
Table 21 RoW Radiopharmaceuticals Market- Diagnosis And Systemic Therapy, 2010-2018 (USD Million)
Table 22 RoW Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)

Enquiry Before Buying




Free Market Analysis




The rise in aging population on a global scale with a decrease in the supply of the Tc-99 isotope has led to commotion in the radiopharmaceuticals market. The large number of nuclear reactors shutting down for maintenance and leakage problems has led to a decrease in the global supply of Mo-99. Additionally, demand has also increased from emerging markets like India and China due to a rise in healthcare awareness and disposable incomes. This has led to an enormous shortage of Mo-99, which is a precursor of Tc-99, used almost 90% of the times in nuclear imaging. This crisis has led to long waiting lists of patients to get these tests done, with some opting for other technologies for their diagnosis. 

Furthermore, the decline in the supply of isotopes has led to a hike in the prices of these tests; as a consequence, they are affordable for only a few people, and would also require out-of-pocket expenditure. Every day, hospitals and clinics around the world use Tc-99 to perform over 100,000 diagnostic procedures. Thus, aging nuclear reactors causing their shutdown coupled with an increase in demand and limited supply has pushed the industry participants to opt for other radioisotopes and find a replacement for TC-99 on a global scale. The North American region is the largest market for radiopharmaceutical usage, followed by Europe and Asia-Pacific. 

North America is the largest market globally for the use of medical isotopes. The region includes two countries, namely the US and Canada. Canada is the largest exporter of uranium and nuclear technology, which now forms the backbone of nuclear medicine and imaging studies. Europe is the second largest market for radiopharmaceuticals. The rise in the aging population, consequently leading to an increase in cardiovascular and neurological disorders, has propelled the growth of the radiopharmaceuticals market in this region. The Asia-Pacific region has been experiencing healthy growth in the radiopharmaceuticals market in countries like Japan, Taiwan, and Korea. Rise in aging population, urbanization, and increasing wealth in low and middle income countries like India and China have led to growth in the Asian region.

global-radiopharmaceuticals-market-by-region-2010-2018
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research